The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 21 articles
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons
August 21, 2023 | 10.4244/EIJ-E-23-00013
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI
Spirito A,
Itchhaporia D,
Sartori S,
Camenzind E,
Chieffo A,
Dangas G,
Galatius S,
Jeger RV,
Kandzari D,
Kastrati A,
Kim H,
Kimura T,
Leon MB,
Mehta LS,
Mikhail G,
Morice M,
Nicolas J,
Pileggi B,
Serruys P,
Smits PC,
Steg PG,
Stone G,
Valgimigli M,
Vogel B,
von Birgelen C,
Weisz G,
Wijns W,
Windecker S,
Mehran R
August 21, 2023 | 10.4244/EIJ-D-23-00086
Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes
Koshy A,
Giustino G,
Sartori S,
Hooda A,
Feng Y,
Snyder C,
Dasgupta S,
Kumar K,
Krishnamoorthy-Melarcode P,
Sweeny J,
Khera S,
Serrao G,
Sharma R,
Dangas G,
Kini A,
Mehran R,
Sharma S
March 20, 2023 | 10.4244/EIJ-D-22-00654
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
Sardella G,
Beerkens F,
Dangas G,
Cao D,
Baber U,
Sartori S,
Cohen D,
Briguori C,
Gil R,
Nicolas J,
Zhang Z,
Dudek D,
Kunadian V,
Kornowski R,
Weisz G,
Claessen B,
Marx S,
Escaned J,
Huber K,
Collier T,
Moliterno D,
Ohman EM,
Krucoff M,
Kastrati A,
Steg G,
Angiolillo D,
Mehta SR,
Shlofmitz RA,
Sharma S,
Pocock S,
Gibson C,
Mehran R
December 2, 2022 | 10.4244/EIJ-D-22-00319
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry
Chandrasekhar J,
Baber U,
Sartori S,
Goel R,
Nicolas J,
Vogel B,
Snyder C,
Kini A,
Briguori C,
Witzenbichler B,
Iakovou I,
Sardella G,
Marzo K,
DeFranco A,
Stuckey T,
Chieffo A,
Colombo A,
Shlofmitz RA,
Capodanno D,
Dangas G,
Pocock S,
Mehran R
October 7, 2022 | 10.4244/EIJ-D-21-01044
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M,
Louvard Y,
Lefèvre T,
Stankovic G,
Burzotta F,
Kassab G,
Lassen JF,
Darremont O,
Garg S,
Koo B,
Holm N,
Johnson TW,
Pan M,
Chatzizisis Y,
Banning A,
Chieffo A,
Dudek D,
Hildick-Smith D,
Garot J,
Henry T,
Dangas G,
Stone G,
Krucoff M,
Cutlip D,
Mehran R,
Wijns W,
Sharif F,
Serruys P,
Onuma Y
May 18, 2022 | 10.4244/EIJ-E-22-00018
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Dangas G,
Baber U,
Sharma S,
Giustino G,
Sartori S,
Nicolas J,
Goel R,
Mehta SR,
Cohen D,
Angiolillo D,
Zhang Z,
Camaj A,
Cao D,
Briguori C,
Dudek D,
Escaned J,
Huber K,
Collier T,
Kornowski R,
Kunadian V,
Moliterno D,
Ohman EM,
Weisz G,
Gil R,
Krucoff M,
Kaul U,
Oldroyd K,
Sardella G,
Shlofmitz RA,
Witzenbichler B,
Kastrati A,
Han Y,
Steg G,
Pocock S,
Gibson CM,
Mehran R
March 18, 2022 | 10.4244/EIJ-D-21-00721
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions
Zimarino M,
Angiolillo D,
Dangas G,
Capodanno D,
Barbato E,
Hahn J,
Giustino G,
Watanabe H,
Costa F,
Cuisset T,
Rossini R,
Sibbing D,
Burzotta F,
Louvard Y,
Shehab A,
Renda G,
Kimura T,
Gwon H,
Chen S,
Costa R,
Koo B,
Storey R,
Valgimigli M,
Mehran R,
Stankovic G
May 16, 2021 | 10.4244/EIJ-D-20-00885
Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial
Kini A,
Dangas G,
Baber U,
Vengrenyuk Y,
Kandzari D,
Leon MB,
Morice M,
Serruys P,
Kappetein A,
Sabik J,
Dressler O,
Mehran R,
Sharma S,
Stone G
June 25, 2020 | 10.4244/EIJ-D-19-00851
Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention
Theodoropoulos K,
Mennuni M,
Sartori S,
Meelu O,
Yu J,
Baber U,
Stefanini G,
Mastoris I,
Moreno P,
Dangas G,
Mehran R,
Sharma S,
Kini A
February 20, 2017 | 10.4244/EIJ-D-15-00409
Effects of baseline and early acquired thrombocytopaenia on long-term mortality in patients undergoing percutaneous coronary intervention with bivalirudin
Ali ZA,
Qureshi Y,
Karimi Galougahi K,
Poludasu S,
Roy S,
Krishnan P,
Zalewski A,
Shah Z,
Bhatti N,
Kalapatapu K,
Mehran R,
Dangas G,
Kini A,
Sharma S
April 8, 2016 | 10.4244/EIJV11I14A314
Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to “mega centre” for patients with ST-segment elevation myocardial infarction
Schoos M,
Pedersen F,
Holmvang L,
Engstrøm T,
Saunamäki K,
Helqvist S,
Kastrup J,
Mehran R,
Dangas G,
Jørgensen E,
Kelbæk H,
Clemmensen P
September 22, 2015 | 10.4244/EIJY14M11_07
Stroke prevention in valvular heart disease: from the procedure to long-term management
September 17, 2015 | 10.4244/EIJV11SWA7
Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty
Kini A,
Yu J,
Cohen M,
Mehran R,
Baber U,
Sartori S,
Vlachojannis GJ,
Kovacic J,
Pyo R,
O’Neill B,
Singh V,
Jacobs E,
Poludasu S,
Moreno P,
Kim M,
Krishnan P,
Sharma S,
Dangas G
July 21, 2014 | 10.4244/EIJV10I3A54
Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials
Geisler T,
Müller K,
Karathanos A,
Bocksch W,
Gawaz M,
Deliargyris E,
Bernstein D,
Lincoff A,
Mehran R,
Dangas G,
Stone G
May 20, 2014 | 10.4244/EIJV10I1A16
Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial
Caixeta A,
Lansky AJ,
Mehran R,
Brener S,
Claessen B,
Généreux P,
Palmerini T,
Witzenbichler B,
Guagliumi G,
Brodie B,
Dudek D,
Fahy M,
Dangas G,
Stone G
June 28, 2013 | 10.4244/EIJV9I2A37
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial
Généreux P,
Mehran R,
Palmerini T,
Caixeta A,
Kirtane AJ,
Lansky AJ,
Brodie B,
Witzenbichler B,
Mockel M,
Guagliumi G,
Peruga J,
Dudek D,
Fahy M,
Dangas G,
Stone G
December 30, 2011 | 10.4244/EIJV7I8A144
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023